transcriptomics
| 2 min read
A $500k award will support a two-phase study enrolling pregnant women to advance understanding of placental dysfunction.
| 4 min read
Multiomic approaches are advancing cancer research by delivering deeper insights and enabling more precise diagnostics and therapies.
| 4 min read
By identifying high-risk pregnancies early, Mirvie’s new RNA-based test opens the door to timely prevention.
| 3 min read
Nonhuman primates treated with the mRNA vaccine recovered faster and had less severe disease than those given available mpox vaccines.
| 4 min read
A new method called “REVeRT” expands the capabilities of gene delivery platforms by transporting larger genes than previously possible.
| 5 min read
The durability and capacity to boost protein expression of circular RNA makes it a promising candidate for next-generation vaccines and gene therapies.
| 3 min read
Targeting α-synuclein mRNA before it had a chance to aggregate reduced its protein levels in cultured dopaminergic neurons and may protect neurons.
| 8 min read
Alnylam Pharmaceuticals develops therapeutics based on the RNA interference (RNAi) pathway discovered in 1998.
| 3 min read
Researchers discovered that where mRNA translation occurs in the cytoplasm changes protein expression level and sometimes even function.
| 6 min read
Researchers use cell-free DNA circulating in the blood of patients with rheumatoid arthritis to match them with the most effective drugs.
